AnserBio
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
47 Hataasiya, Nesher, IsraelWebsite
www.anser-bio.comRevenue
<$5 MillionIndustry
About AnserBio
AnserBio is a pioneering biotechnology company focused on revolutionizing cancer treatment through its innovative p53 therapy, which aims to restore tumor suppression. The company utilizes proprietary cell-derived nanoparticles to deliver functional p53 protein, addressing the high prevalence of p53 mutations in various aggressive cancers. AnserBio targets oncology indications with significant unmet needs, offering a unique therapeutic approach that enhances patient outcomes compared to traditional treatments. Led by co-founders Dr. Lana Volokh and Dr. Alex Tendler, AnserBio is committed to transforming cancer care and improving the lives of millions affected by the disease.Explore more
SIC Code 28,283NAICS Code 32,325Show more
AnserBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AnserBio
Sign Up For FreeTo access detailed company insights
AnserBio is a pioneering biotechnology company focused on revolutionizing cancer treatment through its innovative p53 therapy, which aims to restore tumor suppression. The company utilizes proprietary cell-derived nanoparticles to deliver functional p53 protein, addressing the high prevalence of p53 mutations in various aggressive cancers. AnserBio... Read More
